Pacific Shuanglin Bio-pharmacy Balance Sheet Health
Financial Health criteria checks 6/6
Pacific Shuanglin Bio-pharmacy has a total shareholder equity of CN¥7.8B and total debt of CN¥574.1M, which brings its debt-to-equity ratio to 7.3%. Its total assets and total liabilities are CN¥9.1B and CN¥1.2B respectively. Pacific Shuanglin Bio-pharmacy's EBIT is CN¥903.5M making its interest coverage ratio -10.8. It has cash and short-term investments of CN¥1.8B.
Key information
7.3%
Debt to equity ratio
CN¥574.15m
Debt
| Interest coverage ratio | -10.8x |
| Cash | CN¥1.75b |
| Equity | CN¥7.82b |
| Total liabilities | CN¥1.23b |
| Total assets | CN¥9.05b |
Recent financial health updates
Recent updates
If EPS Growth Is Important To You, Pacific Shuanglin Bio-pharmacy (SZSE:000403) Presents An Opportunity
Oct 10
Pacific Shuanglin Bio-pharmacy Co., LTD's (SZSE:000403) Shares May Have Run Too Fast Too Soon
Aug 16We Think Pacific Shuanglin Bio-pharmacy (SZSE:000403) Can Stay On Top Of Its Debt
Jul 22Is Now The Time To Put Pacific Shuanglin Bio-pharmacy (SZSE:000403) On Your Watchlist?
May 24Financial Position Analysis
Short Term Liabilities: 000403's short term assets (CN¥3.5B) exceed its short term liabilities (CN¥871.5M).
Long Term Liabilities: 000403's short term assets (CN¥3.5B) exceed its long term liabilities (CN¥356.9M).
Debt to Equity History and Analysis
Debt Level: 000403 has more cash than its total debt.
Reducing Debt: 000403's debt to equity ratio has reduced from 19.6% to 7.3% over the past 5 years.
Debt Coverage: 000403's debt is well covered by operating cash flow (118.6%).
Interest Coverage: 000403 earns more interest than it pays, so coverage of interest payments is not a concern.